SKAN Group AG (SKAN) - Total Liabilities

Latest as of December 2025: CHF347.81 Million CHF ≈ $439.73 Million USD

Based on the latest financial reports, SKAN Group AG (SKAN) has total liabilities worth CHF347.81 Million CHF (≈ $439.73 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of SKAN Group AG to track the company's year-over-year net asset growth rate.

SKAN Group AG - Total Liabilities Trend (2012–2025)

This chart illustrates how SKAN Group AG's total liabilities have evolved over time, based on quarterly financial data. See SKAN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

SKAN Group AG Competitors by Total Liabilities

The table below lists competitors of SKAN Group AG ranked by their total liabilities.

Company Country Total Liabilities
Zhejiang Taihua New Material
SHG:603055
China CN¥6.05 Billion
WAVE LIFE SCIENCES LTD.
F:1U5
Germany €71.81 Million
SUPERLOOP LTD
F:9SL
Germany €232.10 Million
Beijing Urban Rural Commercial Group Co Ltd
SHG:600861
China CN¥8.68 Billion
Da An Gene Co Ltd of Sun Yat-Sen University
SHE:002030
China CN¥1.07 Billion
Norion Bank
ST:NORION
Sweden Skr58.20 Billion
Alvotech
IC:ALVO
Iceland Ikr1.59 Billion
WuXi Xinje Electric Co Ltd
SHG:603416
China CN¥988.94 Million

Liability Composition Analysis (2012–2025)

This chart breaks down SKAN Group AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see SKAN Group AG market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 78.94 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 51.61 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 3.04 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.72 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SKAN Group AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SKAN Group AG (2012–2025)

The table below shows the annual total liabilities of SKAN Group AG from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 CHF347.81 Million
≈ $439.73 Million
+91.19%
2024-12-31 CHF181.92 Million
≈ $230.00 Million
-7.69%
2023-12-31 CHF197.09 Million
≈ $249.17 Million
-11.52%
2022-12-31 CHF222.76 Million
≈ $281.62 Million
+41.06%
2021-12-31 CHF157.92 Million
≈ $199.65 Million
-10.77%
2020-12-31 CHF176.98 Million
≈ $223.75 Million
+27663.10%
2019-12-31 CHF637.47K
≈ $805.94K
-75.58%
2018-12-31 CHF2.61 Million
≈ $3.30 Million
+232.78%
2017-12-31 CHF784.46K
≈ $991.77K
-13.71%
2016-12-31 CHF909.15K
≈ $1.15 Million
+78.61%
2015-12-31 CHF509.02K
≈ $643.54K
-61.93%
2014-12-31 CHF1.34 Million
≈ $1.69 Million
+495.92%
2013-12-31 CHF224.39K
≈ $283.69K
-5.48%
2012-12-31 CHF237.39K
≈ $300.13K
--

About SKAN Group AG

SW:SKAN Switzerland Medical Instruments & Supplies
Market Cap
$1.61 Billion
CHF1.27 Billion CHF
Market Cap Rank
#8467 Global
#115 in Switzerland
Share Price
CHF56.50
Change (1 day)
-1.91%
52-Week Range
CHF40.40 - CHF76.40
All Time High
CHF90.75
About

SKAN Group AG, together with its subsidiaries, provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally. It operates in two segments, Equipment and Solutions; and Services and Consumables. The company offers accessories, biological indicators, digital ventures, isolators, cleanroom, laminar f… Read more